1. Neuroendocrine differentiation of prostate cancer cells grown in nude mice in presence of bone marrow stromal cells in androgen deprivation conditions. (July 2016) Authors: Gravina, G.L.; Mancini, A.; Colapietro, A.; Vetuschi, A.; Pompili, S.; Sferra, R.; Monache, S. Delle; Festuccia, C. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S84 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bioclinical Parameters Driving Decision-Making of Subsequent Lines of Treatment in Metastatic Castration-Resistant Prostate Cancer. (27th May 2014) Authors: Irelli, A.; Bruera, G.; Cannita, K.; Palluzzi, E.; Gravina, G. L.; Festuccia, C.; Ficorella, C.; Ricevuto, E. Other Names: Isidori Andrea Maria Academic Editor. Journal: BioMed research international Issue: Volume 2014(2014) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. EP-2062: c-Myc silencing impairs oncophenotype and radioresistance of Embrional Rhabdomyosarcoma Cell Lines. (April 2016) Authors: Marampon, F.; Gravina, G.; Festuccia, C.; Alessandro, C.; Di Cesare, E.; Tombolini, V. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S973 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. EP-2041: Vitamin D protects HUVEC from RT-induced senescence and apoptosis by modulating MAPK/SirT1 axis. (April 2016) Authors: Marampon, F.; Gravina, G.; Festuccia, C.; Colapietro, A.; Di Cesare, E.; Tombolini, V. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S963 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PV-0424: Cyclin D1 silencing radiosensitises prostate cancer cells by impairing DNA-DSBs repair pathways. (April 2016) Authors: Marampon, F.; Gravina, G.; Festuccia, C.; Colapietro, A.; Di Cesare, E.; Tombolini, E. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S198 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. EP-2316: Inhibiting ephrin reverts oncophenotype and radiosensitizes embryonal rhabdomyosarcoma cells. (April 2018) Authors: Marampon, F.; Gravina, G.L.; Festuccia, C.; De Felice, F.; Musio, D.; Tombolini, V. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S1278 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Enhancement of radiosensitivity by the novel anticancer quinolone derivative vosaroxin in preclinical glioblastoma models. (December 2016) Authors: Festuccia, C.; Gravina, G.L.; Mancini, A.; Vitale, F.; Marampon, F.; Colapietro, A.; Rossi, G.; Ventura, L.; Di cesare, E.; Fox, J. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Targeting glioblastoma with UniPR1331, a new and stable bioavailable small molecule inhibiting Eph–ephrin interaction: In vitro and in vivo evidence. (December 2016) Authors: Festuccia, C.; Giorgio, C.; Gravina, G.L.; Castelli, R.; Vacondio, F.; Rusnati, M.; Chiodelli, P.; Barocelli, E.; Lodola, A.; Tognolini, M. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. PO-0980: MEK/ERK pathway sustains radioresistance of embryonal rhabdomyosarcoma stem-like cell population. (May 2017) Authors: Marampon, F.; Gravina, G.; Festuccia, C.; Ciccarelli, C.; De Felice, F.; Musio, D.; Tombolini, V. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S542 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗